GlassScriptPhysician profile
Brian Chace Griffith
NPI 1376659615
$2,552.15
in general payments reported to CMS, 2019-2025
29 companies · $641 in 2025
The $641 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $680 · 2020: $277 · 2021: $134 · 2022: $142 · 2023: $398 · 2024: $280 · 2025: $641.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,318.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $484.66 | 2019-2023 | Myrbetriq |
| Coloplast Corp | $254.86 | 2019-2025 | Speedicath, Titan |
| Boston Scientific Corporation | $228.27 | 2019-2025 | Lithovue, Ams 700, Axonics |
| Teleflex LLC | $225.92 | 2022-2025 | Urolift, Barrigel |
| Janssen Biotech, INC. | $148.19 | 2025 | Carvykti, Rybrevant |
| Sumitomo Pharma America, INC. | $124.52 | 2024-2025 | Gemtesa |
| Axonics, INC. | $119.37 | 2023-2024 | Axonics, Bulkamid |
| Pfizer INC. | $92.83 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $92.54 | 2019-2022 | |
| Urogen Pharma, INC. | $90.46 | 2023-2024 | Jelmyto |
| Antares Pharma, INC. | $85.79 | 2019-2021 | |
| 180 Medical, INC. | $79.34 | 2023-2024 | Cure Catheter |
| Tolmar Pharmaceuticals, INC. | $65.63 | 2019-2021 | |
| Medtronic, INC. | $65.18 | 2023-2025 | Interstim |
| Procept Biorobotics Corporation | $61.38 | 2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Halozyme INC | $47.19 | 2023 | |
| Abbvie INC. | $38.71 | 2025 | |
| Calyxo, INC. | $29.06 | 2025 | Cvac Aspiration System |
| Dendreon Pharmaceuticals LLC | $26.46 | 2025 | Provenge |
| Ferring Pharmaceuticals INC. | $25.57 | 2019-2020 | |
| Myriad Genetic Laboratories, INC. | $23.75 | 2024 | Prolaris |
| Otsuka America Pharmaceutical, INC. | $23.68 | 2023 | Jynarque |
| Merck Sharp & Dohme LLC | $23.66 | 2023 | Welireg, Keytruda, Lynparza |
| Karl Storz Endoscopy-America | $23.22 | 2020 | |
| Cook Medical LLC | $18.31 | 2025 | Litho 150 |
| Valencia Technologies Corporation | $15.32 | 2025 | Ecoin Device Kit |
| Urovant Sciences INC | $13.82 | 2022 | |
| Abc Home Medical Supply, INC. | $13.05 | 2023 | |
| Dentsply Ih INC. | $11.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Griffith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.